BRPI0514359A - derivados de amida do ácido n-(fenil-oxazol-4-il-metoximetil)-ciclohexil-succìnico e compostos relacionados que são usados como ligantes ppar (receptores ativados - proliferadores de peroxisoma) para o tratamento de hiperlipidemia e diabetes - Google Patents
derivados de amida do ácido n-(fenil-oxazol-4-il-metoximetil)-ciclohexil-succìnico e compostos relacionados que são usados como ligantes ppar (receptores ativados - proliferadores de peroxisoma) para o tratamento de hiperlipidemia e diabetesInfo
- Publication number
- BRPI0514359A BRPI0514359A BRPI0514359-4A BRPI0514359A BRPI0514359A BR PI0514359 A BRPI0514359 A BR PI0514359A BR PI0514359 A BRPI0514359 A BR PI0514359A BR PI0514359 A BRPI0514359 A BR PI0514359A
- Authority
- BR
- Brazil
- Prior art keywords
- oxazol
- phenyl
- related compounds
- activated receptors
- hyperlipidemia
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 208000031226 Hyperlipidaemia Diseases 0.000 title 1
- 101150014691 PPARA gene Proteins 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 239000003614 peroxisome proliferator Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000670727 Amida Species 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 1
- 125000004350 aryl cycloalkyl group Chemical group 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
DERIVADOS DE AMIDA DO áCIDO N-(FENIL-OXAZOL-4IL-METOXIMETIL)-CICLOHEXIL-SUCCìNICO E COMPOSTOS RELACIONADOS QUE SãO USADOS COMO LIGANTES PPAR (RECEPTORES ATIVADOS - PROLIFERADORES DE PEROXISOMA) PARA O TRATAMENTO DE HIPERLIPIDEMIA E DIABETE. A presente invenção refere-se aos derivados de ácido alcanóico substituídos por aril-cicloalquila, além disso aos sais fisiologicamente compatíveis destes e derivados fisiologicamente funcionais. A invenção também refere-se aos compostos de fórmula (I), em que os radicais têm o significado acima mencionado, além disso aos sais fisiologicamente compatíveis destes e ao método para a produção destes. Os compostos são adequados, por exemplo, para tratamento e/ou prevenção de distúrbios do metabolismo de ácido graxo e distúrbios de utilização de glicose, em adição aos distúrbios, em que a resistência à insulina faz parte.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004039509A DE102004039509B4 (de) | 2004-08-14 | 2004-08-14 | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2005/008282 WO2006018116A1 (de) | 2004-08-14 | 2005-07-30 | N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-bernsteinsäureamid derivate und werwandte verbindungen als ppar-liganden (peroxisomen-proliferatoren-aktivierte rezeptoren) zur behandlung von hyperlipidämie und diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514359A true BRPI0514359A (pt) | 2008-06-10 |
Family
ID=35385508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514359-4A BRPI0514359A (pt) | 2004-08-14 | 2005-07-30 | derivados de amida do ácido n-(fenil-oxazol-4-il-metoximetil)-ciclohexil-succìnico e compostos relacionados que são usados como ligantes ppar (receptores ativados - proliferadores de peroxisoma) para o tratamento de hiperlipidemia e diabetes |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7598281B2 (pt) |
| EP (1) | EP1789403B1 (pt) |
| JP (1) | JP2008509892A (pt) |
| KR (1) | KR20070040812A (pt) |
| CN (1) | CN101006066A (pt) |
| AR (1) | AR053526A1 (pt) |
| AT (1) | ATE426596T1 (pt) |
| AU (1) | AU2005274493A1 (pt) |
| BR (1) | BRPI0514359A (pt) |
| CA (1) | CA2576554A1 (pt) |
| DE (2) | DE102004039509B4 (pt) |
| DK (1) | DK1789403T3 (pt) |
| ES (1) | ES2324675T3 (pt) |
| IL (1) | IL181009A0 (pt) |
| MX (1) | MX2007000614A (pt) |
| PE (1) | PE20060640A1 (pt) |
| PT (1) | PT1789403E (pt) |
| TW (1) | TW200621732A (pt) |
| UY (1) | UY29065A1 (pt) |
| WO (1) | WO2006018116A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113562A (en) | 1998-06-01 | 2000-09-05 | Peter M. Bonutti | Shoulder orthosis |
| US6502577B1 (en) | 2000-09-18 | 2003-01-07 | Peter M. Bonutti | Method for moving finger joints |
| US6503213B2 (en) | 2000-12-01 | 2003-01-07 | Peter M. Bonutti | Method of using a neck brace |
| US6575926B2 (en) | 2000-12-15 | 2003-06-10 | Bonutti 2003 Trust-A | Myofascial strap |
| US8066656B2 (en) | 2005-10-28 | 2011-11-29 | Bonutti Research, Inc. | Range of motion device |
| US7452342B2 (en) | 2004-03-08 | 2008-11-18 | Bonutti Research Inc. | Range of motion device |
| US8012108B2 (en) | 2005-08-12 | 2011-09-06 | Bonutti Research, Inc. | Range of motion system and method |
| CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
| EP2107896A4 (en) | 2007-02-05 | 2010-03-10 | Bonutti Res Inc | KNEE ORTHESIS |
| US8273043B2 (en) | 2007-07-25 | 2012-09-25 | Bonutti Research, Inc. | Orthosis apparatus and method of using an orthosis apparatus |
| US8905950B2 (en) | 2008-03-04 | 2014-12-09 | Bonutti Research, Inc. | Shoulder ROM orthosis |
| EP2486923B1 (en) * | 2011-02-11 | 2015-09-09 | Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG | Histone deacetylase (HDAC) inhibiting compounds and method of making same |
| US9402759B2 (en) | 2013-02-05 | 2016-08-02 | Bonutti Research, Inc. | Cervical traction systems and method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1177176E (pt) * | 1999-04-28 | 2006-08-31 | Aventis Pharma Gmbh | Derivados de acidos triarilicos como ligandos de receptores ppar. |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| JP4436129B2 (ja) * | 2001-08-31 | 2010-03-24 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ジアリールシクロアルキル誘導体、その製造法及びｐｐａｒ−活性剤としてのその使用 |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
-
2004
- 2004-08-14 DE DE102004039509A patent/DE102004039509B4/de not_active Expired - Fee Related
-
2005
- 2005-07-30 EP EP05773889A patent/EP1789403B1/de not_active Expired - Lifetime
- 2005-07-30 ES ES05773889T patent/ES2324675T3/es not_active Expired - Lifetime
- 2005-07-30 AU AU2005274493A patent/AU2005274493A1/en not_active Abandoned
- 2005-07-30 DK DK05773889T patent/DK1789403T3/da active
- 2005-07-30 BR BRPI0514359-4A patent/BRPI0514359A/pt not_active IP Right Cessation
- 2005-07-30 PT PT05773889T patent/PT1789403E/pt unknown
- 2005-07-30 CN CNA2005800276576A patent/CN101006066A/zh active Pending
- 2005-07-30 CA CA002576554A patent/CA2576554A1/en not_active Abandoned
- 2005-07-30 AT AT05773889T patent/ATE426596T1/de not_active IP Right Cessation
- 2005-07-30 DE DE502005006955T patent/DE502005006955D1/de not_active Expired - Lifetime
- 2005-07-30 WO PCT/EP2005/008282 patent/WO2006018116A1/de not_active Ceased
- 2005-07-30 JP JP2007525216A patent/JP2008509892A/ja not_active Abandoned
- 2005-07-30 MX MX2007000614A patent/MX2007000614A/es active IP Right Grant
- 2005-07-30 KR KR1020077003480A patent/KR20070040812A/ko not_active Withdrawn
- 2005-08-05 PE PE2005000910A patent/PE20060640A1/es not_active Application Discontinuation
- 2005-08-11 AR ARP050103352A patent/AR053526A1/es not_active Application Discontinuation
- 2005-08-11 TW TW094127240A patent/TW200621732A/zh unknown
- 2005-08-12 UY UY29065A patent/UY29065A1/es unknown
-
2007
- 2007-01-28 IL IL181009A patent/IL181009A0/en unknown
- 2007-02-07 US US11/672,302 patent/US7598281B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101006066A (zh) | 2007-07-25 |
| UY29065A1 (es) | 2006-02-24 |
| WO2006018116A1 (de) | 2006-02-23 |
| ATE426596T1 (de) | 2009-04-15 |
| AU2005274493A1 (en) | 2006-02-23 |
| DE102004039509A1 (de) | 2006-03-23 |
| EP1789403B1 (de) | 2009-03-25 |
| KR20070040812A (ko) | 2007-04-17 |
| AR053526A1 (es) | 2007-05-09 |
| PE20060640A1 (es) | 2006-07-27 |
| DE502005006955D1 (de) | 2009-05-07 |
| MX2007000614A (es) | 2007-03-30 |
| IL181009A0 (en) | 2007-07-04 |
| CA2576554A1 (en) | 2006-02-23 |
| TW200621732A (en) | 2006-07-01 |
| PT1789403E (pt) | 2009-05-19 |
| DK1789403T3 (da) | 2009-07-06 |
| JP2008509892A (ja) | 2008-04-03 |
| ES2324675T3 (es) | 2009-08-12 |
| EP1789403A1 (de) | 2007-05-30 |
| DE102004039509B4 (de) | 2006-09-21 |
| US7598281B2 (en) | 2009-10-06 |
| US20070197605A1 (en) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1009637A2 (pt) | composto, composição e uso de um composto | |
| MA27707A1 (fr) | Derives aryles et heteroaryles tri-substitues en position 1,2,3 en tant que modulateurs de metabolisme et prophylaxie et traitement de troubles lies au metabolisme | |
| EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
| BRPI0818533B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto | |
| BR0317458A (pt) | EnanciÈmero-s, composto, formulação farmacêutica, método para tratar ou previnir distúrbios de lipìdeos (dislipdemia) associados ou não com resistência à insulina, uso de um composto, método para tratar ou previnir diabetes tipo 2, processo para a preparação de um composto, e, composição farmacêutica | |
| BR112015000373A2 (pt) | metódo para produzir composto de politiol, composição polimerizável para material ótico e usos dos mesmos | |
| BRPI0518222A (pt) | composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos | |
| BR112013021236A8 (pt) | composto, composição,e, método de tratamento de um distúrbio, uma condição ou uma doença | |
| BRPI0409924A (pt) | ácidos amino carboxìlicos substituìdos | |
| BRPI0716069A2 (pt) | composto, composiÇço farmacÊutica, e, mÉtodo para tratar um distérbio | |
| BRPI0910439B8 (pt) | derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos | |
| AR070487A1 (es) | Derivados de 3- metil- imidazo -( 1,2-b)- piridazina | |
| BRPI0409916A (pt) | ácidos carboxìlicos substituìdos com fenila | |
| BR112021020441A2 (pt) | Derivados de pirrolotriazina para tratar doenças mediadas por kit e pdgfra | |
| BRPI0507501A (pt) | composto, composição farmacêutica, uso do composto, método para o tratamento de distúrbios mediados por mglur5, e, método para inibir a ativação de receptores de mglur5 | |
| NO20054957L (no) | Subtituerte karboksylsyrer | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| ECSP11010782A (es) | Derivados de 4,5-dihidro-oxazol-2-ilo | |
| BR112012010124A2 (pt) | composto, uso de um animal composto, derivado de cromenona, e, método para o tratamento ou prevenção de um animal de sangue quente tendo tumores que são sensíveis á inibição das enzimas de pi 3-cinase | |
| BRPI0412997A (pt) | derivados de dióxido de tiazol-benzoisotiazol substituìdos, método para produzir os mesmos e seu uso | |
| BR112012011105A2 (pt) | derivados de oxazolina para tratamento de doenças do snc | |
| BRPI0515081B8 (pt) | composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida | |
| BR112013018839A2 (pt) | métodos e composições para o tratamento, a redução ou a prevenção de deterioração do sistema visual dos animais | |
| BRPI0514448A (pt) | derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias | |
| BRPI0413584A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de doenças e para tratamento de um distúrbio no sistema nervoso central |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 7A ANUIDADE. |